$AVD
AMERICAN VANGUARD CORP

2013 Q4 Form 10-Q Financial Statement

#000119312513422840 Filed on November 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2013 Q2
Revenue $75.52M $97.20M $86.76M
YoY Change -27.57% 8.2% 2.27%
Cost Of Revenue $43.20M $54.04M $44.70M
YoY Change -25.0% 7.63% -3.86%
Gross Profit $32.34M $43.16M $42.07M
YoY Change -29.35% 8.92% 9.7%
Gross Profit Margin 42.82% 44.4% 48.48%
Selling, General & Admin $23.90M $22.90M $24.10M
YoY Change 5.29% 5.53% 26.18%
% of Gross Profit 73.9% 53.06% 57.29%
Research & Development $6.900M $5.100M $5.100M
YoY Change 23.21% 8.51% 2.0%
% of Gross Profit 21.34% 11.82% 12.12%
Depreciation & Amortization $3.670M $3.720M $3.760M
YoY Change 2.8% 29.62% 5.03%
% of Gross Profit 11.35% 8.62% 8.94%
Operating Expenses $30.80M $28.03M $29.17M
YoY Change 9.22% 5.91% 21.01%
Operating Profit $1.541M $15.13M $12.90M
YoY Change -91.23% 14.96% -9.44%
Interest Expense -$400.0K $464.0K $701.0K
YoY Change -33.33% -33.81% -2.77%
% of Operating Profit -25.96% 3.07% 5.44%
Other Income/Expense, Net
YoY Change
Pretax Income $1.100M $14.69M $12.23M
YoY Change -93.49% 16.32% -10.31%
Income Tax $400.0K $5.559M $3.961M
% Of Pretax Income 36.36% 37.84% 32.4%
Net Earnings $278.0K $8.870M $8.386M
YoY Change -97.54% 9.83% -4.09%
Net Earnings / Revenue 0.37% 9.13% 9.67%
Basic Earnings Per Share $0.01 $0.32 $0.29
Diluted Earnings Per Share $0.01 $0.30 $0.29
COMMON SHARES
Basic Shares Outstanding 28.66M shares 28.32M shares 28.30M shares
Diluted Shares Outstanding 28.89M shares 28.89M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.700M $12.30M $32.40M
YoY Change -82.6% -47.88% -32.5%
Cash & Equivalents $6.680M $12.33M $32.41M
Short-Term Investments
Other Short-Term Assets $17.90M $17.30M $18.30M
YoY Change -3.76% 118.99% 315.91%
Inventory $139.8M $127.2M $127.2M
Prepaid Expenses
Receivables $74.06M $109.3M $67.38M
Other Receivables $892.0K $2.500M $1.500M
Total Short-Term Assets $249.5M $268.6M $246.8M
YoY Change 12.23% 16.36% 19.74%
LONG-TERM ASSETS
Property, Plant & Equipment $52.47M $51.64M $49.83M
YoY Change 14.81% 14.25% 2.95%
Goodwill
YoY Change
Intangibles $107.0M $108.6M $110.2M
YoY Change -5.74%
Long-Term Investments $2.701M $3.301M
YoY Change
Other Assets $38.46M $34.57M $30.37M
YoY Change 109.59% 242.27% 640.78%
Total Long-Term Assets $197.9M $194.9M $190.4M
YoY Change 11.47% 16.82% 15.07%
TOTAL ASSETS
Total Short-Term Assets $249.5M $268.6M $246.8M
Total Long-Term Assets $197.9M $194.9M $190.4M
Total Assets $447.4M $463.4M $437.2M
YoY Change 11.89% 16.55% 17.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.70M $32.76M $23.95M
YoY Change 23.95% 2.71% 0.64%
Accrued Expenses $53.63M $95.72M $88.51M
YoY Change 65.86% 30.77% 38.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $69.00K $71.00K $70.00K
YoY Change -99.58% -99.54% -99.54%
Total Short-Term Liabilities $110.5M $142.6M $123.1M
YoY Change -2.79% 15.74% 18.28%
LONG-TERM LIABILITIES
Long-Term Debt $51.68M $38.89M $40.91M
YoY Change 42.77% 1.02% -0.22%
Other Long-Term Liabilities $4.143M $3.900M $4.300M
YoY Change -23.28% -26.42% -23.21%
Total Long-Term Liabilities $55.82M $38.89M $40.91M
YoY Change 54.21% -11.2% -12.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $110.5M $142.6M $123.1M
Total Long-Term Liabilities $55.82M $38.89M $40.91M
Total Liabilities $189.6M $204.6M $187.5M
YoY Change 8.71% 12.28% 13.08%
SHAREHOLDERS EQUITY
Retained Earnings $202.5M $203.6M $196.2M
YoY Change 16.2%
Common Stock $3.109M $3.100M $3.099M
YoY Change 1.04%
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.738M $4.804M $4.804M
YoY Change 40.26%
Treasury Stock Shares 2.381M shares 2.311M shares 2.311M shares
Shareholders Equity $258.0M $258.6M $249.6M
YoY Change
Total Liabilities & Shareholders Equity $447.4M $463.4M $437.2M
YoY Change 11.89% 16.55% 17.66%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income $278.0K $8.870M $8.386M
YoY Change -97.54% 9.83% -4.09%
Depreciation, Depletion And Amortization $3.670M $3.720M $3.760M
YoY Change 2.8% 29.62% 5.03%
Cash From Operating Activities -$13.41M -$12.85M $38.19M
YoY Change -149.08% -45.48% -13.73%
INVESTING ACTIVITIES
Capital Expenditures -$2.970M -$3.930M -$3.960M
YoY Change 9.19% 112.43% -46.05%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.970M -$3.930M -$3.970M
YoY Change -52.02% 112.43% -45.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.10M -3.190M -11.38M
YoY Change -259.31% -576.12% 257.86%
NET CHANGE
Cash From Operating Activities -13.41M -12.85M 38.19M
Cash From Investing Activities -2.970M -3.930M -3.970M
Cash From Financing Activities 10.10M -3.190M -11.38M
Net Change In Cash -6.280M -19.97M 22.84M
YoY Change -142.46% -19.31% -32.33%
FREE CASH FLOW
Cash From Operating Activities -$13.41M -$12.85M $38.19M
Capital Expenditures -$2.970M -$3.930M -$3.960M
Free Cash Flow -$10.44M -$8.920M $42.15M
YoY Change -134.75% -58.93% -18.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.07
CY2013Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23624000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
383701 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.71
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
692012 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.39
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.96
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1177000
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
242036000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
383701 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.71
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
678679 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.87
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.07
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1479000
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249746000
CY2013Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30997686 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
383201 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.72
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
668013 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.60
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2927 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.20
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2310634 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2013Q3 us-gaap Number Of Interest Rate Derivatives Held
NumberOfInterestRateDerivativesHeld
1 Contract
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2013Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
11271000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
71000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
142592000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1472000
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
258833000
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38894000
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
76807000
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58181000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
32764000
CY2013Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
263419000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
258615000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
203610000
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
393000
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
95722000
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
543000
CY2013Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3932000
CY2013Q3 us-gaap Minority Interest
MinorityInterest
218000
CY2013Q3 us-gaap Long Term Debt
LongTermDebt
38965000
CY2013Q3 us-gaap Liabilities
Liabilities
204581000
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1635000
CY2013Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
736000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
3100000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
463414000
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
19163000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34569000
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
108641000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
109318000
CY2013Q3 us-gaap Inventory Net
InventoryNet
127172000
CY2013Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4877000
CY2013Q3 us-gaap Equity Method Investments
EquityMethodInvestments
3301000
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
128449000
CY2013Q3 us-gaap Cash
Cash
12325000
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4804000
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
114754000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51642000
CY2013Q3 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
4288000
CY2013Q3 us-gaap Assets
Assets
463414000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12325000
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
12418000
CY2013Q3 us-gaap Other Receivables
OtherReceivables
2489000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12381000
CY2013Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
111807000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
268562000
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28660282 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35085000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30766730 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
245817 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.70
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
705345 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.23
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.95
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2310634 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2012Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
8671000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
16247000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
113670000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1762000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
225436000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36196000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70458000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54323000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32838000
CY2012Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
229881000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
225077000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
174243000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20427000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32335000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
623000
CY2012Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5425000
CY2012Q4 us-gaap Minority Interest
MinorityInterest
359000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
52443000
CY2012Q4 us-gaap Liabilities
Liabilities
174454000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1839000
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1313000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3077000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
399890000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
19163000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18351000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
113521000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76073000
CY2012Q4 us-gaap Inventory Net
InventoryNet
87951000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4877000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
116159000
CY2012Q4 us-gaap Cash
Cash
38476000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4804000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
74900000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45701000
CY2012Q4 us-gaap Assets
Assets
399890000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38476000
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
13051000
CY2012Q4 us-gaap Other Receivables
OtherReceivables
1230000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13710000
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
77303000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
222317000
CY2013Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-04-19
CY2013Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-04-05
dei Trading Symbol
TradingSymbol
AVD
dei Entity Registrant Name
EntityRegistrantName
AMERICAN VANGUARD CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000005981
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28890000 shares
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7200000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
12290000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-386000
us-gaap Sales Revenue Net
SalesRevenueNet
305499000
us-gaap Payments Of Dividends
PaymentsOfDividends
3390000
us-gaap Profit Loss
ProfitLoss
33830000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
280297000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
46000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28295000 shares
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15977000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-520000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-341000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
25202000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
57000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3687000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
485000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
52716000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-195000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14564000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1415000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34461000
us-gaap Gross Profit
GrossProfit
139006000
us-gaap Operating Income Loss
OperatingIncomeLoss
54183000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
34304000
us-gaap Net Income Loss
NetIncomeLoss
34171000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39221000
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
-596000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
245000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17223000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26000000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2895000
us-gaap Operating Expenses
OperatingExpenses
84823000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
130000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18500000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-151000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-20034000
us-gaap Interest Expense
InterestExpense
1712000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
412000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
929000
us-gaap Cost Of Revenue
CostOfRevenue
166493000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
64088000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11183000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
38750000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
57000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
2976000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6154000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
34216000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28673000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13101000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27818000 shares
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
14908000
us-gaap Sales Revenue Net
SalesRevenueNet
261928000
us-gaap Payments Of Dividends
PaymentsOfDividends
1380000
us-gaap Profit Loss
ProfitLoss
25554000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
234045000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6000000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
493000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
87000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39965000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
428000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8862000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26069000
us-gaap Gross Profit
GrossProfit
115349000
us-gaap Operating Income Loss
OperatingIncomeLoss
41809000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
36515000
us-gaap Net Income Loss
NetIncomeLoss
25554000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21747000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
313000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10087000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11894000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1856000
us-gaap Operating Expenses
OperatingExpenses
73540000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
592000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14411000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
433000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6270000
us-gaap Interest Expense
InterestExpense
2157000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8743000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3260000
us-gaap Cost Of Revenue
CostOfRevenue
146579000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
37623000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9915000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
493000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
2061000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6460000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14908000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
644000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
27883000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
25554000
CY2013Q3 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-10-18
CY2013Q3 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-10-04
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3687000
CY2013Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-07-19
CY2013Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-07-05
CY2013Q2 avd Cash Dividend Paid
CashDividendPaid
1976000
CY2013Q3 avd Cash Dividend Paid
CashDividendPaid
1413000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.50
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
22.17
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6666 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6667 shares
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.27
CY2013Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.50
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
8000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
145884 shares
CY2013Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
378000
CY2013Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
57000
CY2013Q1 us-gaap Profit Loss
ProfitLoss
16819000
CY2013Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
178000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
407000
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
688000
CY2013Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1976000
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2013Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
49000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
585000
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
8230 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
30.37
CY2013Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13333 shares
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.19
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.50
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
8230 shares
CY2013Q2 us-gaap Profit Loss
ProfitLoss
8266000
CY2013Q2 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
174000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-476000
CY2013Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
101000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-302000
CY2013Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1058000
CY2013Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1413000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28878000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27970000 shares
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
89836000
CY2012Q3 us-gaap Profit Loss
ProfitLoss
8076000
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
78864000
CY2012Q3 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
41000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12629000
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
306000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8423000
CY2012Q3 us-gaap Gross Profit
GrossProfit
39625000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
13165000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
8076000
CY2012Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
165000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
26460000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4553000
CY2012Q3 us-gaap Interest Expense
InterestExpense
701000
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
50211000
CY2012Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
10972000
CY2012Q3 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
8076000
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.50
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2013Q3 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
200000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28889000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
5000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
8.32
CY2013Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6666 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.27
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28322000 shares
CY2013Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.50
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
4500 shares
CY2013Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
365000
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-386000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
97201000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
8745000
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
87608000
CY2013Q3 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
133000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14690000
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-126000
CY2013Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
36000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8877000
CY2013Q3 us-gaap Gross Profit
GrossProfit
43159000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15134000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
8870000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
CY2013Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1149000
CY2013Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
20000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
28025000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5559000
CY2013Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1415000
CY2013Q3 us-gaap Interest Expense
InterestExpense
464000
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
54042000
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-125000
CY2013Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
9593000
CY2013Q3 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
9131000

Files In Submission

Name View Source Status
0001193125-13-422840-index-headers.html Edgar Link pending
0001193125-13-422840-index.html Edgar Link pending
0001193125-13-422840.txt Edgar Link pending
0001193125-13-422840-xbrl.zip Edgar Link pending
avd-20130930.xml Edgar Link completed
avd-20130930.xsd Edgar Link pending
avd-20130930_cal.xml Edgar Link unprocessable
avd-20130930_def.xml Edgar Link unprocessable
avd-20130930_lab.xml Edgar Link unprocessable
avd-20130930_pre.xml Edgar Link unprocessable
d607568d10q.htm Edgar Link pending
d607568dex311.htm Edgar Link pending
d607568dex312.htm Edgar Link pending
d607568dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending